Gd-EOB-DTPA-enhanced MR imaging: Prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 5, 2012, Pages 1148-1153

  Goshima, Satoshi ^a   Kanematsu, Masayuki ^a   Watanabe, Haruo ^a   Kondo, Hiroshi ^a   Kawada, Hiroshi ^a   Moriyama, Noriyuki ^b   Bae, Kyongtae T ^c  

^a GIFU UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

cirrhosis; gadoxetate disodium; Gd EOB DTPA; liver; MRI

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER FIBROSIS; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPLEEN SIZE;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPLEEN;

EID: 84867760454     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23758     Document Type: Article

References (24)

1. Afdhal NH, Nunes D,. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99: 1160-1174.
2. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
3. Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE,. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 2007; 25: 122-128.
4. Koinuma M, Ohashi I, Hanafusa K, Shibuya H,. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005; 22: 80-85.
5. Lewin M, Poujol-Robert A, Boelle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007; 46: 658-665.
6. Sandrasegaran K, Akisik FM, Lin C, et al. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 2009; 193: 1556-1560.
7. Hagiwara M, Rusinek H, Lee VS, et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging-initial experience. Radiology 2008; 246: 926-934.
8. Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007; 245: 458-466.
9. Rouviere O, Yin M, Dresner MA, et al. MR elastography of the liver: preliminary results. Radiology 2006; 240: 440-448.
10. Kim H, Taksali SE, Dufour S, et al. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. Magn Reson Med 2008; 59: 521-527.
11. Kim T, Murakami T, Hasuike Y, et al. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 1997; 7: 683-688.
12. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U,. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183: 59-64.
13. Ichida F, Tsuji T, Omata M, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996; 6: 112-119.
14. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H,. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1991; 22: 233-237; discussion 242.
15. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195: 785-792.
16. Ni Y, Marchal G, Lukito G, Yu J, Muhler A, Baert AL,. MR imaging evaluation of liver enhancement by Gd-EOB-DTPA in selective and total bile duct obstruction in rats: correlation with serologic, microcholangiographic, and histologic findings. Radiology 1994; 190: 753-758.
17. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T,. Cirrhosis: modified caudate-right lobe ratio. Radiology 2002; 224: 769-774.
18. Watanabe H, Kanematsu M, Goshima S, et al. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging-preliminary observations. Radiology 2011; 259: 142-150.
19. Zhou XP, Lu T, Wei YG, Chen XZ,. Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT. AJR Am J Roentgenol 2007; 189: W153-W159.
20. Harbin WP, Robert NJ, Ferrucci JT Jr,. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 1980; 135: 273-283.
21. Giorgio A, Amoroso P, Lettieri G, et al. Cirrhosis: value of caudate to right lobe ratio in diagnosis with US. Radiology 1986; 161: 443-445.
22. Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME,. Computed tomography of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr 1986; 10: 47-50.
23. Liu P, Li P, He W, Zhao LQ,. Liver and spleen volume variations in patients with hepatic fibrosis. World J Gastroenterol 2009; 15: 3298-3302.
24. Murata Y, Abe M, Hiasa Y, et al. Liver/spleen volume ratio as a predictor of prognosis in primary biliary cirrhosis. J Gastroenterol 2008; 43: 632-636.